IGC Pharma, Inc. — Director's Dealing 2021

Sep 15, 2021

SEC Form 5/A — Form 5/A

Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2021-03-31

Reporting Person: GRIMALDI CLAUDIA (Vice President & PFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-03	Common Stock	G	100000	—	Disposed	937987	Direct
2021-05-13	Common Stock	G	500000	—	Disposed	437987	Direct
2021-05-13	Common Stock	A	250000	—	Acquired	687987	Direct

Footnotes

F1: Represents restricted shares of common stock subject to vesting over three years.

F2: This Form 5 is being filed to reflect the correct ownership amount of the Reporting Person. Section 16 filings of the Reporting Person filed on May 17, 2021 overstated the Reporting Person's ownership by 100,000 shares. Accordingly, the Reporting person owns 687,987 shares of Common Stock as opposed to the 787,987 shares previously reported on the Form 5.